{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:38Z","timestamp":1793237678001,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015394","name":"American Society for Transplantation and Cellular Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006521","name":"Stanford University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.04.010","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:27:21Z","timestamp":1776011241000},"page":"4070-4083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model"],"prefix":"10.1016","volume":"34","author":[{"given":"Carla","family":"Dib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Queenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Willner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Swartzrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten T.","family":"Charlesworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina J.","family":"Mepani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalena","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Nakauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2909-2669","authenticated-orcid":false,"given":"Agnieszka","family":"Czechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.04.010_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.13310","article-title":"Severe combined immunodeficiency diagnosis and genetic defects","volume":"322","author":"Aranda","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2026.04.010_bib2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A modified \u03b3-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2013-01-476432","article-title":"SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID","volume":"123","author":"Schuetz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood.2021012300","article-title":"Built to last: gene therapy for ADA SCID","volume":"138","author":"Pai","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib6","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1182\/blood-2022-159979","article-title":"Therapy with Low Dose Conditioning for X-Linked SCID Results in Complete Immune Reconstitution and No Evidence of Clonal Expansion","volume":"140","author":"Booth","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2500\/aap.2024.45.240069","article-title":"Hematopoietic stem cell transplantation for primary immunodeficiency","volume":"45","author":"Alsaati","year":"2024","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.ymthe.2026.04.010_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.humimm.2022.03.002","article-title":"A clinician's guide to HLA matching in allogeneic hematopoietic stem cell transplant","volume":"83","author":"Mangum","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.010_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10875-020-00898-0","article-title":"Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes","volume":"41","author":"Klein","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.010_bib10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbmt.2019.03.009","article-title":"Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children","volume":"25","author":"Neven","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.ymthe.2026.04.010_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/hum.1993.4.4-513","article-title":"Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID","volume":"4","author":"Bordignon","year":"1993","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.04.010_bib12","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2019-123432","article-title":"Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)","volume":"134","author":"Kohn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.04.010_bib14","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.04.010_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/toxsci\/kfw220","article-title":"Viral Vectors: The Road to Reducing Genotoxicity","volume":"155","author":"David","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ymthe.2026.04.010_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.04.010_bib17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","article-title":"Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"391","author":"Duncan","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0820","article-title":"Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1","volume":"9","author":"Schiroli","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtn.2022.12.006","article-title":"Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs","volume":"31","author":"Iancu","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.04.010_bib21","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib22","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1038\/s41467-019-13620-5","article-title":"Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib23","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1093\/nar\/gkaa603","article-title":"CRISPR\/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells","volume":"48","author":"Geisinger","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.04.010_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/0008-5472.CAN-21-1692","article-title":"CRISPR\/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.04.010_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.04.010_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0070-x","article-title":"Publisher Correction: Programmable base editing of A T to G C in genomic DNA without DNA cleavage","volume":"559","author":"Gaudelli","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.04.010_bib27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41576-018-0068-0","article-title":"Publisher Correction: Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.04.010_bib28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa2300709","article-title":"Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia","volume":"389","author":"Chiesa","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib29","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J. Hum. Immun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.04.010_bib31","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ymthe.2024.03.028","article-title":"Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing","volume":"32","author":"Zhang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.010_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood-2024-204888","article-title":"Initial Results from the BEACON Clinical Study: A Phase 1\/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises","volume":"144","author":"Gupta","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","article-title":"Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins","volume":"10","author":"Mangeot","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib34","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/nar\/gkz605","article-title":"Delivering Cas9\/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing","volume":"47","author":"Lyu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.04.010_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12076","article-title":"Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing","volume":"10","author":"Yao","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2026.04.010_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109207","article-title":"Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering","volume":"35","author":"Hamilton","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.04.010_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymthe.2018.10.002","article-title":"Gesicle-Mediated Delivery of CRISPR\/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus","volume":"27","author":"Campbell","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.04.010_bib38","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.cell.2025.03.015","article-title":"Engineered nucleocytosolic vehicles for loading of programmable editors","volume":"188","author":"Geilenkeuser","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.04.010_bib39","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1038\/s41467-025-64181-9","article-title":"Engineering a streamlined virus-like particle for programmable tissue-specific gene delivery","volume":"16","author":"Han","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02915-2","article-title":"In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles","author":"Botchkarev","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.04.010_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-026-10235-x","article-title":"In vivo site-specific engineering to reprogram T cells","volume":"652","author":"Nyberg","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.04.010_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41551-020-00671-z","article-title":"In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA","volume":"5","author":"Villiger","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.04.010_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/crispr.2020.0095","article-title":"Adenine Base Editor Ribonucleoproteins Delivered by Lentivirus-Like Particles Show High On-Target Base Editing and Undetectable RNA Off-Target Activities","volume":"4","author":"Lyu","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.04.010_bib44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","article-title":"Lentivirus pre-packed with Cas9 protein for safer gene editing","volume":"23","author":"Choi","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.04.010_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.04.010_bib46","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.04.010_bib47","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1084\/jem.20090778","article-title":"Niche recycling through division-independent egress of hematopoietic stem cells","volume":"206","author":"Bhattacharya","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood.V116.21.74.74","article-title":"Targeted Clearance of Human Hematopoietic Stem Cell Niches Via Inhibition of SCF Signaling Using Monoclonal Antibody SR-1","volume":"116","author":"Czechowicz","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41467-018-08201-x","article-title":"Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation","volume":"10","author":"Czechowicz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib50","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1182\/blood-2018-06-853879","article-title":"Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice","volume":"133","author":"Kwon","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib51","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood-2018-06-858159","article-title":"Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice","volume":"133","author":"Pang","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib52","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.bbmt.2018.12.172","article-title":"Toxicity-Free Hematopoietic Stem Cell Engraftment Achieved with Anti-CD117 Monoclonal Antibody Conditioning","volume":"25","author":"Agarwal","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymthe.2026.04.010_bib53","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2021-153074","article-title":"JSP191 As a Single-Agent Conditioning Regimen Results in Successful Engraftment, Donor Myeloid Chimerism, and Production of Donor Derived Na\u00efve Lymphocytes in Patients with Severe Combined Immunodeficiency (SCID)","volume":"138","author":"Agarwal","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib54","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.04.010_bib55","doi-asserted-by":"crossref","first-page":"18993","DOI":"10.1073\/pnas.0709170104","article-title":"The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2","volume":"104","author":"Ram\u00f3n-Maiques","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.04.010_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature09755","article-title":"The RAG2 C terminus suppresses genomic instability and lymphomagenesis","volume":"471","author":"Deriano","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.04.010_bib57","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1073\/pnas.0237043100","article-title":"Deletion of the RAG2 C terminus leads to impaired lymphoid development in mice","volume":"100","author":"Akamatsu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.04.010_bib58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1182\/blood-2014-02-558163","article-title":"Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs","volume":"124","author":"Girard-Gagnepain","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.04.010_bib59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/bloodadvances.2018027508","article-title":"Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency","volume":"3","author":"Bernadin","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2026.04.010_bib60","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1038\/s41467-025-61449-y","article-title":"GFP-on mouse model for interrogation of in vivo gene editing","volume":"16","author":"Dib","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib61","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1089\/crispr.2020.0106","article-title":"Lentiviral Capsid-Mediated","volume":"4","author":"Lu","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.04.010_bib62","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.04.010_bib63","first-page":"164.e1","article-title":"Non-genotoxic Restoration of the Hematolymphoid System in Fanconi Anemia","volume":"29","author":"Chan","year":"2023","journal-title":"Transpl. Cel. Ther."},{"key":"10.1016\/j.ymthe.2026.04.010_bib64","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.stemcr.2016.04.010","article-title":"Single Targeted Exon Mutation Creates a True Congenic Mouse for Competitive Hematopoietic Stem Cell Transplantation: The C57BL\/6-CD45.1(STEM) Mouse","volume":"6","author":"Mercier","year":"2016","journal-title":"Stem Cel Rep."},{"key":"10.1016\/j.ymthe.2026.04.010_bib65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fimmu.2018.00172","article-title":"Establishment of the Reference Intervals of Lymphocyte Function in Healthy Adults Based on IFN-\u03b3 Secretion Assay upon Phorbol-12-Myristate-13-Acetate\/Ionomycin Stimulation","volume":"9","author":"Hou","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.010_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.04.010_bib67","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","article-title":"The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions","volume":"151","author":"Dvorak","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2026.04.010_bib68","first-page":"601","article-title":"Novel Humanized Particles for Efficient Delivery of CRISPR and Other Gene Editors","volume":"32","author":"Cabeceiras","year":"2024","journal-title":"In MOLECULAR THERAPY"},{"key":"10.1016\/j.ymthe.2026.04.010_bib69","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.omtn.2018.05.010","article-title":"VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9","volume":"12","author":"Montagna","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.04.010_bib70","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1038\/s41467-023-40788-8","article-title":"Cell type-specific delivery by modular envelope design","volume":"14","author":"Strebinger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.04.010_bib71","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/bloodadvances.2023009668","article-title":"Physioxia improves the selectivity of hematopoietic stem cell expansion cultures","volume":"7","author":"Igarashi","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2026.04.010_bib72","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1038\/s41586-019-1395-9","article-title":"Author Correction: Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation","volume":"571","author":"Wilkinson","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.04.010_bib73","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.04.010_bib74","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:26:39Z","timestamp":1793237199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525001626002753"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.010","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}